U.S. Invokes Title 42 for 30 Days After American Catches Ebola in 131-Death Outbreak
Updated
Updated · KSBW Monterey · May 19
U.S. Invokes Title 42 for 30 Days After American Catches Ebola in 131-Death Outbreak
9 articles · Updated · KSBW Monterey · May 19
A U.S. physician working in the DRC tested positive for Ebola as officials arranged to move seven people, including the patient, to Germany for treatment.
131 deaths and 513 suspected cases have been linked to the outbreak in Congo, while Uganda has reported two confirmed cases in Kampala, one of them fatal.
The CDC on Monday activated Title 42 for at least 30 days, tightening screening for arrivals and restricting some non-U.S. passport holders who recently traveled through the DRC, Uganda or South Sudan.
WHO has labeled the outbreak an international public health emergency and warned the Bundibugyo strain could spread further because it has no approved vaccine or treatment.
Fighting and aid cuts in eastern Congo have weakened surveillance and care, with health workers saying delayed detection and strained clinics are hampering containment.
Could U.S. travel bans worsen the Ebola crisis despite WHO warnings against them?
We knew this Ebola strain existed, so why was the world caught completely unprepared for its deadly return?
With no approved vaccine, could an experimental drug be the only hope against this deadly Ebola strain?
Bundibugyo Ebola Crisis 2026: U.S. Travel Restrictions, International Policy Debate, and Urgent Lessons for Global Health
Overview
In May 2026, the U.S. government announced a 30-day travel ban under Title 42 in response to the escalating Ebola outbreak, mainly affecting non-U.S. citizens from severely impacted regions like Congo, Uganda, and South Sudan. While most U.S. travelers are not directly affected unless they recently visited these countries, the government is actively working with the Democratic Republic of Congo and Uganda to contain the virus at its source. The decision was influenced by Ebola’s long incubation period, which allows exposed individuals to travel internationally while asymptomatic, making routine screening less effective and increasing the risk of cross-border spread.